The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,502,418 in first-year total cost, median $275,453.
Most frequent study sections
- Special Emphasis Panel[ZES1 LWJ-W (R4)]3
Most frequent institutions
- LITRON LABORATORIES, LTD.1
- NORTIS, INC.1
- VIVOVERSE, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | The Next-Generation Developmental and Reproductive Toxicology (DART) Assay using High-Content Analysis of Genetically Diverse C. elegans Populations2R44ES033579-02 | HEGARTY, EVAN | VIVOVERSE, LLC, TX | $996,687 | ZES1 |
| 2023 | A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds1R44ES035556-01 | NEUMANN, THOMAS | NORTIS, INC., WA | $275,453 | ZES1 |
| 2023 | Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors1R43ES035550-01 | BEMIS, JEFFREY CDERTINGER, STEPHEN D | LITRON LABORATORIES, LTD., NY | $230,278 | ZES1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.